These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 26294808

  • 1. Carboxyhemoglobin Formation in Preterm Infants Is Related to the Subsequent Development of Bronchopulmonary Dysplasia.
    Tokuriki S, Okuno T, Ohta G, Ohshima Y.
    Dis Markers; 2015; 2015():620921. PubMed ID: 26294808
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.
    Sheikh S, Null D, Gentile D, Bimle C, Skoner D, McCoy K, Guthrie R.
    Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia: a marker of severity?
    Kalra VK, Aggarwal S, Arora P, Natarajan G.
    Pediatr Pulmonol; 2014 Nov; 49(11):1106-11. PubMed ID: 24214578
    [Abstract] [Full Text] [Related]

  • 8. Role of NT-proBNP in the prediction of moderate to severe Bronchopulmonary Dysplasia in preterm infants.
    Khan S, Concina VA, Schneider D, Westgate P, Arriagada S, Bada H.
    Pediatr Pulmonol; 2020 Feb; 55(2):376-382. PubMed ID: 31869001
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma Proendothelin-1 as an Early Marker of Bronchopulmonary Dysplasia.
    Baumann P, Fouzas S, Pramana I, Grass B, Niesse O, Bührer C, Spanaus K, Wellmann S.
    Neonatology; 2015 Feb; 108(4):293-6. PubMed ID: 26355291
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Red cell distribution width as a predictor for bronchopulmonary dysplasia in premature infants.
    Go H, Ohto H, Nollet KE, Sato K, Ichikawa H, Kume Y, Kanai Y, Maeda H, Kashiwabara N, Ogasawara K, Sato M, Hashimoto K, Hosoya M.
    Sci Rep; 2021 Mar 31; 11(1):7221. PubMed ID: 33790386
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
    Falciglia HS, Johnson JR, Sullivan J, Hall CF, Miller JD, Riechmann GC, Falciglia GA.
    Am J Perinatol; 2003 Feb 31; 20(2):97-107. PubMed ID: 12660915
    [Abstract] [Full Text] [Related]

  • 20. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
    Sellmer A, Hjortdal VE, Bjerre JV, Schmidt MR, McNamara PJ, Bech BH, Henriksen TB.
    PLoS One; 2015 Feb 31; 10(10):e0140079. PubMed ID: 26452045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.